Company Overview and News
ATLANTA, Oct. 11, 2018 (GLOBE NEWSWIRE) -- WestRock Company (NYSE: WRK), a leading provider of differentiated paper and packaging solutions, today provided an initial update following the landfall of Hurricane Michael and its impact on the company’s containerboard and pulp mill located in Panama City, Florida.
2018-10-10 marketwatch - 1
Goldman Sachs downgraded International Paper Co. stock IP, -0.81% to neutral from buy on Wednesday, and removed WestRock Co. WRK, -2.41% from its Americas Conviction List. It kept a neutral rating on Packaging Corp. of America PKG, -2.60% while lowering stock price targets for all three as it expects U.S. containerboard supply growth to outpace demand growth in the period from 2020 to 2022. Analyst Brian Maguire said he had upgraded International Paper and added WestRock to the conviction last year because he expected U.
IP INPAP WRK
One may not have heard of the name, but WestRock Company (WRK) is a multinational provider of paper and packaging for customers across the world. Do you know all of those boxes that items come in - such as beverage, wine, paper and even pizza boxes come from? WestRock could be a huge reason behind it. It doesn't stop there. Walk around your grocery store, and you may see the packaging for your favorite ice cream, frozen dinner or a box of your favorite pasta or mac and cheese.
The end of 2018 is rapidly approaching. With only three months to go, I am working hard to identify different investment opportunities. With some extra cash, I am ready to put my capital to work and increase my dividend income as much as possible before the end of the year. In this month's edition of my dividend stock watch list, I identified four stocks that I will keep an eye on. Ironically, I actually own all four stocks on this watch list.
IRM NG NGGTF WRK ED NGG
ATLANTA, Oct. 05, 2018 (GLOBE NEWSWIRE) -- WestRock (NYSE: WRK), a leading provider of differentiated paper and packaging solutions, was recognized at the Path to Purchase Design of the Times Awards with 31 awards for excellence in merchandising solutions — the most of any entrant for the second year in row. The company’s awards include a platinum award for Harry’s Dude and Dog endcap.
Heading into Friday's Non Farm Payrolls (NFP) report for September, economists are expecting an increase in payrolls of 184K, which would be a modest decline from August's stronger-than-expected reading of 201K. In the private sector, economists are expecting an increase of 180K. The unemployment rate is expected to tick down to 3.8% from last month's reading of 3.9%. Average hourly earnings are expected to grow at a rate of 0.
ATLANTA, Oct. 03, 2018 (GLOBE NEWSWIRE) -- WestRock Company (NYSE: WRK) today announced that it will host a conference call to discuss its fourth quarter and full year fiscal 2018 results, as well as other topics, on Monday, Nov. 5, at 8:30 am ET. WestRock will release its fourth quarter and full year fiscal 2018 results prior to market open on Monday, Nov. 5.
ATLANTA, Sept. 18, 2018 (GLOBE NEWSWIRE) -- WestRock Company (NYSE: WRK), a leading provider of differentiated paper and packaging solutions, today provided an update following the landfall of Hurricane Florence.
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to WRK / Westrock Company on message board site Silicon Investor.
as of ET